Lysocardiolipin Acyltransferase 1 (LCLAT1) Peptide
LCLAT1
适用: 哺乳动物
宿主: 合成
BP, WB, IHC
-
- 抗原 See all LCLAT1 products
- LCLAT1 (Lysocardiolipin Acyltransferase 1 (LCLAT1))
- 蛋白类型
- Synthetic
- 宿主
- 哺乳动物
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- 序列
- YLYSLVKWYF IITIVIFVLQ ERIFGGLEII ELACYRLLHK QPHLNSKKNE
- 产品特性
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LYCAT antibody,
Alternative Names: LYCAT control peptide, LYCAT antibody Blocking Peptide, Anti-LYCAT Blocking Peptide, Lysocardiolipin Acyltransferase Blocking Peptide, ALCAT1 Blocking Peptide, FLJ37965 Blocking Peptide, UNQ1849 Blocking Peptide
-
-
- 应用备注
- Optimal conditions should be determined by the investigator
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- 缓冲液
- PBS
- 注意事项
- Avoid repeated freeze/thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- Store at -20 °C long term.
-
- 抗原
- LCLAT1 (Lysocardiolipin Acyltransferase 1 (LCLAT1))
- 背景
- LYCAT is an acyl-CoA:lysocardiolipin acyltransferase. It possesses both lysophosphatidylinositol acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase (LPGAT) activities. LYCAT recognises both monolysocardiolipin and dilysocardiolipin as substrates with a preference for linoleoyl-CoA and oleoyl-CoA as acyl donors. LYCAT acts as a remodeling enzyme for cardiolipin, a major membrane polyglycerophospholipid. It converts lysophosphatidic acid (LPA) into phosphatidic acid (PA) with a relatively low activity. LYCAT is required for establishment of the hematopoietic and endothelial lineages.
- 分子量
- 44 kDa
-
You are here:
